Why Shares of Apollomics Are Up Friday
The company just went public in March and recently received coverage and a buy rating from an analyst.
Source: fool.com
📰 Crown Bioscience News
Page 3 - Crown Bioscience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Crown Bioscience. Real-time updates on events, politics, business and more.
Why Shares of Apollomics Are Up Friday
The company just went public in March and recently received coverage and a buy rating from an analyst.
Source: fool.com
JSR Life Sciences Announces Operational Consolidation of KBI Biopharma, Inc. and Selexis SA to Operate as one Organization, Providing Seamless Experience for Partners
KBI's new model will enhance operational efficiencies, drive strategic clarity, and accelerate innovation for global biopharma customers JSR Life Sciences today announced that KBI Biopharma, Inc.
Source: finanznachrichten.de
JSR Life Sciences Announces Operational Consolidation of KBI Biopharma Inc. and Selexis SA to Operate as one Organization Providing Seamless Experience for Partners
JSR Life Sciences today announced that KBI Biopharma Inc. KBI and Selexis SA are consolidating as one organization under the KBI Biopharma name to accelerate innovation and growth for its global biopharma customers.
Source: businesswireindia.com
Global Humanized Mouse and Rat Model Market Report 2023:
Dublin, May 22, 2023 (GLOBE NEWSWIRE) -- The "Global Humanized Mouse and Rat Model Market by Type (Genetic, Cell-based (CD34, PBMC, BLT)), Application...
United States Hera Biolabs Crown Bioscience Cyagen Biosciences Ozgene Pty Research Activities Using Humanized Models
Source: globenewswire.com
Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the Summit Therapeutics First Quarter 2023 Earnings and Update Call. [Operator Instructions].
Source: insidermonkey.com
Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2023
First US Patient Treated in Ivonescimab Clinical Trial after Closing Agreement; $500M Raised in Fully-Subscribed Rights Offering ... | May 11, 2023
Source: marketscreener.com
Global Pharma, Biotech & Diagnostics Co-promotion and
Dublin, April 20, 2023 (GLOBE NEWSWIRE) -- The "Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics...
Source: globenewswire.com
Investegate |Biognosys AG Announcements | Biognosys AG: Biognosys Presenting Novel Cancer Research on its Proteomics Platforms and Advancing Data Analysis with the Launch of Proteoverse™ at the AACR Annual Meeting 2023
Investegate announcements from Biognosys AG, Biognosys Presenting Novel Cancer Research on its Proteomics Platforms and Advancing Data Analysis with the Launch of Proteoverse™ at the AACR Annual Meeting 2023
United States United Kingdom Kristina Beeler Jakob Vowinckel Biognosys Truetarget Biognosys Truesignature
Source: investegate.co.uk
Biognosys AG: Biognosys Presenting Novel Cancer Research on its Proteomics Platforms and Advancing Data Analysis with the Launch of Proteoverse at the AACR Annual Meeting 2023
In collaboration with prominent biopharma companies and academic institutions, Biognosys will demonstrate the technological advances and versatility of the TrueDiscovery, TrueTarget, and TrueSignature
United Kingdom United States Biognosys Truetarget Biognosys Truediscovery Nigel Beaton Crown Bioscience
Source: finanznachrichten.de